Proposal Could Cut Time to Clinical Trials in Brazil

Drug Industry Daily
Drugmakers could see their wait time to begin clinical trials in Brazil cut by more than a third under a proposed regulation calling for protocols to be reviewed in their entirety, rather than stage by stage, which is the current policy.

To View This Article:


Subscribe To Drug Industry Daily